Piccirillo MC, Bonanno L, Garassino MC, Esposito G, et al. Addition of bevacizumab to erlotinib as first-line treatment of patients with EGFR-mutated advanced nonsquamous non-small cell lung cancer. The BEVERLY multicenter randomized phase III trial. J Thorac Oncol 2022 Jun 1. pii: S1556-0864(22)00268.
PMID: 35659580